IRB InvIT Fund [IRBINVIT] vs Paras Defence [PARAS] Detailed Stock Comparison
IRB InvIT Fund
BSE
Loading...
Paras Defence
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: IRB InvIT Fund wins in 13 metrics, Paras Defence wins in 4 metrics, with 0 ties. IRB InvIT Fund appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | IRB InvIT Fund | Paras Defence | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.29 | 84.04 | IRB InvIT Fund |
| Price-to-Book Ratio | N/A | 8.41 | N/A |
| Debt-to-Equity Ratio | 0.84 | 3.77 | IRB InvIT Fund |
| PEG Ratio | N/A | -1.63 | N/A |
| EV/EBITDA | 7.73 | 55.56 | IRB InvIT Fund |
| Profit Margin (TTM) | 91.34% | 16.96% | IRB InvIT Fund |
| Operating Margin (TTM) | 60.05% | 19.28% | IRB InvIT Fund |
| EBITDA Margin (TTM) | 60.05% | 19.28% | IRB InvIT Fund |
| Return on Equity | 9.34% | 9.97% | Paras Defence |
| Return on Assets (TTM) | 2.88% | 7.45% | Paras Defence |
| Free Cash Flow (TTM) | $6.95B | $95.90M | IRB InvIT Fund |
| Dividend Yield | 16.10% | 0.08% | IRB InvIT Fund |
| 1-Year Return | -0.82% | -44.78% | IRB InvIT Fund |
| Price-to-Sales Ratio (TTM) | 3.38 | 14.37 | IRB InvIT Fund |
| Enterprise Value | $68.59B | $52.88B | IRB InvIT Fund |
| EV/Revenue Ratio | 6.33 | 14.13 | IRB InvIT Fund |
| Gross Profit Margin (TTM) | 91.51% | 53.28% | IRB InvIT Fund |
| Revenue per Share (TTM) | $19 | $47 | Paras Defence |
| Earnings per Share (Diluted) | $6.13 | $7.94 | Paras Defence |
| Beta (Stock Volatility) | N/A | 0.44 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
IRB InvIT Fund vs Paras Defence Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| IRB InvIT Fund | 0.00% | 2.45% | 2.75% | 16.66% | 13.45% | 4.75% |
| Paras Defence | 1.36% | 2.71% | -15.91% | -54.54% | -26.91% | -33.66% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| IRB InvIT Fund | -0.82% | 12.16% | 59.32% | -37.41% | -37.41% | -37.41% |
| Paras Defence | -44.78% | 3.96% | 35.50% | 35.50% | 35.50% | 35.50% |
Performance & Financial Health Analysis: IRB InvIT Fund vs Paras Defence
| Metric | IRBINVIT | PARAS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹36.62B | ₹53.77B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 30,293 | 545,209 |
| 90 Day Avg. Volume | 169,095 | 858,164 |
| Last Close | ₹63.09 | ₹676.30 |
| 52 Week Range | ₹49.95 - ₹66.90 | ₹608.60 - ₹1,945.00 |
| % from 52W High | -5.70% | -65.23% |
| All-Time High | ₹105.00 (May 15, 2017) | ₹1,945.00 (May 19, 2025) |
| % from All-Time High | -39.91% | -65.23% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.00% | 0.12% |
| Quarterly Earnings Growth | 0.05% | 0.00% |
| Financial Health | ||
| Profit Margin (TTM) | 0.91% | 0.17% |
| Operating Margin (TTM) | 0.60% | 0.19% |
| Return on Equity (TTM) | 0.09% | 0.10% |
| Debt to Equity (MRQ) | 0.84 | 3.77 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | N/A | ₹79.34 |
| Cash per Share (MRQ) | N/A | ₹13.75 |
| Operating Cash Flow (TTM) | ₹7.54B | ₹-103,800,000 |
| Levered Free Cash Flow (TTM) | ₹3.56B | ₹634.70M |
| Dividends | ||
| Last 12-Month Dividend Yield | 16.10% | 0.08% |
| Last 12-Month Dividend | ₹10.00 | ₹0.50 |
Valuation & Enterprise Metrics Analysis: IRB InvIT Fund vs Paras Defence
| Metric | IRBINVIT | PARAS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.29 | 84.04 |
| Forward P/E | N/A | 39.96 |
| PEG Ratio | N/A | -1.63 |
| Price to Sales (TTM) | 3.38 | 14.37 |
| Price to Book (MRQ) | N/A | 8.41 |
| Market Capitalization | ||
| Market Capitalization | ₹36.62B | ₹53.77B |
| Enterprise Value | ₹68.59B | ₹52.88B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.33 | 14.13 |
| Enterprise to EBITDA | 7.73 | 55.56 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.44 |
| Book Value per Share (MRQ) | N/A | ₹79.34 |
Financial Statements Comparison: IRB InvIT Fund vs Paras Defence
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IRBINVIT | PARAS |
|---|---|---|
| Revenue/Sales | ₹2.64B | ₹931.90M |
| Cost of Goods Sold | ₹212.62M | ₹435.40M |
| Gross Profit | ₹2.43B | ₹496.50M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹1.66B | ₹179.70M |
| EBITDA | ₹2.21B | ₹242.60M |
| Pre-Tax Income | ₹1.02B | ₹194.50M |
| Income Tax | ₹18.75M | ₹51.80M |
| Net Income (Profit) | ₹1.01B | ₹142.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IRBINVIT | PARAS |
|---|---|---|
| Cash & Equivalents | ₹7.93M | ₹344.70M |
| Total Current Assets | ₹6.61B | ₹5.98B |
| Total Current Liabilities | ₹5.14B | ₹1.91B |
| Long-Term Debt | ₹29.29B | ₹12.80M |
| Total Shareholders Equity | ₹40.06B | ₹6.37B |
| Retained Earnings | ₹-9.08B | N/A |
| Property, Plant & Equipment | ₹0 | ₹1.79B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IRBINVIT | PARAS |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | IRBINVIT | PARAS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 30,293 | 545,209 |
| Average Daily Volume (90 Day) | 169,095 | 858,164 |
| Shares Outstanding | 580.50M | 80.59M |
| Float Shares | N/A | 34.92M |
| % Held by Insiders | 0.00% | 0.56% |
| % Held by Institutions | 0.19% | 0.06% |
Dividend Analysis & Yield Comparison: IRB InvIT Fund vs Paras Defence
| Metric | IRBINVIT | PARAS |
|---|---|---|
| Last 12-Month Dividend | ₹10.00 | ₹0.50 |
| Last 12-Month Dividend Yield | 16.10% | 0.08% |
| 3-Year Avg Annual Dividend | ₹9.35 | ₹0.17 |
| 3-Year Avg Dividend Yield | 3.23% | 0.08% |
| 3-Year Total Dividends | ₹28.05 | ₹0.50 |
| Ex-Dividend Date | Jul 24, 2025 | Aug 08, 2025 |